Civic Intelligence

Center for Clinical Innovation

EIN 46-1637647 • 501(c)3 • Half Moon Bay, CA

Revoked

Profile

The Mission of the Center for Clinical Innovation is to significantly improve the patients journey and outcomes by funding innovative, patient-centered clinical research and initiatives leading to scalable and replicable results around the world.

Revocation date: May 15, 2018

320 Fairway DriveHalf Moon Bay, CA 94019

n/A

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

65th percentile

0.01x

Higher debt load relative to assets than 65% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2014

Liabilities / Revenue

66th percentile

0.01x

Higher debt load relative to revenue than 66% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2014

Net Margin

97th percentile

95%

Higher net margin than 97% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2014

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2014

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2014

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2014

Balance Sheet
Liabilities / Assets65th percentile

Assets

$19,033

No earlier filing loaded for comparison.

Liabilities

$100

No earlier filing loaded for comparison.

Net Assets

$18,933

No earlier filing loaded for comparison.

Operations
Liabilities / Revenue66th percentileNet Margin97th percentile

Revenue

$20,000

No earlier filing loaded for comparison.

Expenses

$1,067

No earlier filing loaded for comparison.

Net Income

$18,933

No earlier filing loaded for comparison.

Trend Graphs

Balance Sheet Trend

Asset GrowthScore unavailable

Grouped bars show assets, liabilities, and net assets across loaded filings.

$20K$15K$10K$5.0K$0Assets 2014: $19,033Liabilities 2014: $100Net Assets 2014: $18,9332014

Highlighted filing

2014

Assets$19,033
Liabilities$100
Net Assets$18,933
Open 2014 Filing

Operations Trend

Revenue GrowthScore unavailable

Revenue, expenses, and net income by year, with the latest filing highlighted.

$20K$15K$10K$5.0K$0Revenue 2014: $20,000Expenses 2014: $1,067Net Income 2014: $18,9332014

Highlighted filing

2014

Revenue$20,000
Expenses$1,067
Net Income$18,933
Open 2014 Filing

Filings

Most recent year

2014 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$19,033
Liabilities
$100
Net assets
$18,933
Revenue
$20,000
Expenses
$1,067
Net income
$18,933
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2014Detailed filing. Detailed filing data is available for this year.$19.0$0.10$18.9$20.0$1.07$18.9
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2014 to Dec 31, 2014
Signed
May 14, 2015
Return Version
2014v5.0
Gross Receipts
$20,000
Mission and Program Overview

Mission

The Mission of the Center for Clinical Innovation is to significantly improve the patients journey and outcomes by funding innovative, patient-centered clinical research and initiatives leading to scalable and replicable results around the world.

Program Services

DescriptionGrantsExpenses
The organization was formed on November 19, 2012. To date the Center for Clinical Innovation remains inactive. We anticipate receiving funding in mid-2015 and will begin operations then as follows:Project #1: I-SPY 3 Clinical Trial process:I-SPY 3 is a ground-breaking process for conducting Phase III clinical trials for new cancer cures. It was started as a research project by the University of California at San Francisco (UCSF) Breast Cancer Center. Its transformative design results in a 3X improvement in time, cost and patient volunteers for testing of, and FDA approval for new cancer treatments (see chart below). The first service offering will be I-SPY 3 for breast cancer - a companion Phase III clinical trial network for drugs which have demonstrated a very high likelihood for success in a Phase II trial by virtue of having graduated from the breast cancer I-SPY 2 trial or another neo-adjuvant trial. As of March, 2015, there have been 9 novel breast cancer treatments which have either graduated from, or are enrolling patients in, the I-SPY 2 Trial. These drugs will all need I-SPY 3, which is the companion Phase III trial for commercial release of the drugs. Traditional Phase III Trial I-SPY 3 TrialCost $100M - $500M $60M - $200MTime 8-12 years 4-6 yearsPatients Required 1,000 6,000 600 2,000 The societal benefit of the I-SPY methodology is much faster approval of new cancer treatments and at lower costs for cancer patients. The FDA is an enthusiastic supporter of I-SPY trial methodology and many other disease groups (lung cancer, Alzheimers, melanoma, etc.) are organizing Master Trial platforms similar to I-SPY. enCompass Health Foundation will raise funds and provide grants for the I-SPY 3 researchers University of California at San Francisco to support their efforts in this regard.Project #2: BreastCancerTrials.org BreastCancerTrials.org is a non-profit service that is dedicated to providing accurate information about breast cancer clinical trials. Its patient-centered website includes trials funded by the National Cancer Institute, public research foundations, and the pharmaceutical/biotechnology industry.BreastCancerTrials.org is now nationally available at http://www.BreastCancerTrials.org. The free service is sponsored by the NCI, QuantumLeap HealthCare and the Center of Excellence for Breast Cancer Care. Women who participate in the service are guided through a process of creating a personal health record within a secure database that summarizes their cancer diagnosis and treatment.The database also includes a registry of breast cancer clinical trials with associated eligibility criteria. Trials are matched to patient data, and patients are notified of any matches that occur. They can then choose to contact researchers to learn more about these trials and, if interested, release their health record directly to a researcher for further review of eligibility. Participants have access to system support by email or phone.$1,067-
Compensation and Service Providers
Top Officer Pay81st percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Alan C HuPresident & CEOPT$0--
Bethany HornthalSecretary-$0--
Laura EssermanTreasurer-$0--
Filing and Contact Details

Filer

Filer Name
Center for Clinical Innovation
EIN
46-1637647
Phone
2024879524
Address
320 Fairway Drive, Half Moon Bay, CA 94019

Signing Officer

Name
Alan C Hu
Title
President & CEO
Signed
2015-05-14
Discuss with paid preparer
Yes

Preparer

Firm
Susan E Rojas EA
Address
553 Laidley Street, San Francisco, CA 94131
Preparer
Susan E Rojas
Phone
4152721593
Supplemental Narrative

Additional Explanations

Other Expenses.1002

“Office Expenses $961”

Total Liabilities.1

“Due to Quantum Leap Health Care - Beginning $0 Due to Quantum Leap Health Care - Ending $100”

Raw XML Appendix129 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0Susan Rojas
IRS990EZ/BooksInCareOfDetail/PhoneNum04152721593
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt03450 California Street
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0San Francisco
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd094118
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt019033
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt020000
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt018933
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form720FiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt00
IRS990EZ/Form990TotalAssetsGrp/EOYAmt019033
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GrossReceiptsAmt020000
IRS990EZ/GrossReceiptsForPublicUseAmt00
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/InitiationFeesAndCapContriAmt00
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesEOYAmt018933
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt00
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt018933
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt010.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt12.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt22.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Alan C Hu
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Bethany Hornthal
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Laura Esserman
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0President & CEO
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Secretary
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Treasurer
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationFiled990TInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt0961
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0The Mission of the Center for Clinical Innovation is to significantly improve the patients journey and outcomes by funding innovative, patient-centered clinical research and initiatives leading to scalable and replicable results around the world.
IRS990EZ/PrintingPublicationsPostageAmt0106
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0The organization was formed on November 19, 2012. To date the Center for Clinical Innovation remains inactive. We anticipate receiving funding in mid-2015 and will begin operations then as follows:Project #1: I-SPY 3 Clinical Trial process:I-SPY 3 is a ground-breaking process for conducting Phase III clinical trials for new cancer cures. It was started as a research project by the University of California at San Francisco (UCSF) Breast Cancer Center. Its transformative design results in a 3X improvement in time, cost and patient volunteers for testing of, and FDA approval for new cancer treatments (see chart below). The first service offering will be I-SPY 3 for breast cancer - a companion Phase III clinical trial network for drugs which have demonstrated a very high likelihood for success in a Phase II trial by virtue of having graduated from the breast cancer I-SPY 2 trial or another neo-adjuvant trial. As of March, 2015, there have been 9 novel breast cancer treatments which have either graduated from, or are enrolling patients in, the I-SPY 2 Trial. These drugs will all need I-SPY 3, which is the companion Phase III trial for commercial release of the drugs. Traditional Phase III Trial I-SPY 3 TrialCost $100M - $500M $60M - $200MTime 8-12 years 4-6 yearsPatients Required 1,000 6,000 600 2,000 The societal benefit of the I-SPY methodology is much faster approval of new cancer treatments and at lower costs for cancer patients. The FDA is an enthusiastic supporter of I-SPY trial methodology and many other disease groups (lung cancer, Alzheimers, melanoma, etc.) are organizing Master Trial platforms similar to I-SPY. enCompass Health Foundation will raise funds and provide grants for the I-SPY 3 researchers University of California at San Francisco to support their efforts in this regard.Project #2: BreastCancerTrials.org BreastCancerTrials.org is a non-profit service that is dedicated to providing accurate information about breast cancer clinical trials. Its patient-centered website includes trials funded by the National Cancer Institute, public research foundations, and the pharmaceutical/biotechnology industry.BreastCancerTrials.org is now nationally available at http://www.BreastCancerTrials.org. The free service is sponsored by the NCI, QuantumLeap HealthCare and the Center of Excellence for Breast Cancer Care. Women who participate in the service are guided through a process of creating a personal health record within a secure database that summarizes their cancer diagnosis and treatment.The database also includes a registry of breast cancer clinical trials with associated eligibility criteria. Trials are matched to patient data, and patients are notified of any matches that occur. They can then choose to contact researchers to learn more about these trials and, if interested, release their health record directly to a researcher for further review of eligibility. Participants have access to system support by email or phone.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt01067
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/RelatedOrgSect527OrgInd0false
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt0100
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt01067
IRS990EZ/TotalProgramServiceExpensesAmt01067
IRS990EZ/TotalRevenueAmt020000
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0N/A
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt020000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt020000
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt00
IRS990ScheduleA/OtherIncome170Grp/TotalAmt00
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.00000
IRS990ScheduleA/PublicSupportTotal170Amt020000
IRS990ScheduleA/SubstantialContributorsTotAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft170Grp/TotalAmt00
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt020000
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt020000
IRS990ScheduleA/TotalSupportAmt020000
IRS990ScheduleA/UnrelatedBusinessNetIncm170Grp/TotalAmt00
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Office Expenses $961
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Due to Quantum Leap Health Care - Beginning $0 Due to Quantum Leap Health Care - Ending $100
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Other Expenses.1002
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Total Liabilities.1
ReturnHeader/BuildTS02016-03-07 17:11:31Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0Alan C Hu
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0President & CEO
ReturnHeader/BusinessOfficerGrp/SignatureDt02015-05-14
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0Center for Clinical Innovation
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0dba enCompass Health Foundation
ReturnHeader/Filer/BusinessNameControlTxt0CENT
ReturnHeader/Filer/EIN0461637647
ReturnHeader/Filer/PhoneNum02024879524
ReturnHeader/Filer/USAddress/AddressLine1Txt0320 Fairway Drive
ReturnHeader/Filer/USAddress/CityNm0Half Moon Bay
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd094019
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Susan E Rojas EA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0553 Laidley Street
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0San Francisco
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd094131
ReturnHeader/PreparerPersonGrp/PhoneNum04152721593
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0Susan E Rojas
ReturnHeader/PreparerPersonGrp/SelfEmployedInd0X
ReturnHeader/ReturnTs02015-05-14T18:24:46-07:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02014-01-01
ReturnHeader/TaxPeriodEndDt02014-12-31
ReturnHeader/TaxYr02014

Document Assets

No mirrored PDF or thumbnail assets are attached yet.